PMID- 30919241 OWN - NLM STAT- MEDLINE DCOM- 20211108 LR - 20211108 IS - 1993-0402 (Electronic) IS - 1672-0415 (Linking) VI - 27 IP - 1 DP - 2021 Jan TI - Humulus lupulus L. Extract Prevents Ovariectomy-Induced Osteoporosis in Mice and Regulates Activities of Osteoblasts and Osteoclasts. PG - 31-38 LID - 10.1007/s11655-019-2700-z [doi] AB - OBJECTIVE: To systematically evaluate the protective effects of Humulus lupulus L. extract (HLE) on osteoporosis mice. METHODS: In vivo experiment, a total of 35 12-week-old female ICR mice were equally divided into 5 groups: the sham control group (sham); the ovariectomy with vehicle group (OVX); the OVX with estradiol valerate [EV, 0.2 mg/(kg*d)] the OVX with low- or high-dose HLE groups [HLE, 1 g/(kg*d) and 3 g/(kg*d)], 7 in each group. Treatment began 1 week after the ovariectomized surgery and lasted for 12 weeks. Bone mass and trabecular bone mircoarchitecture were evaluated by micro computed tomography, and bone turnover markers in serum were evaluated using enzyme-linked immunosorbent assay (ELISA) kits. In vitro experiment, osteoblasts and osteoclasts were treated with HLE at doses of 0, 4, 20 and 100 microg/mL. Biomarkers for bone formation in osteoblasts and bone resorption in osteoclasts were analyzed. RESULTS: Compared with the OVX group, HLE exerted bone protective effects by the increase of estradiol (P<0.05), the improvement of cancellous bone structure, bone mineral density (P<0.01) and the reduction of serum alkaline phosphatase (ALP), tartrate resistant acid phosphatase (TRAP), bone gla-protein, c-terminal telopeptides of type I collagen (CTX-I) and deoxypyridinoline levels (P<0.01 for all). In vitro experiment, compared with the control group, HLE at 20 microg/mL promoted the cell proliferation (P<0.01), and increased the expression of bone morphogenetic protein-2 and osteopontin levels in osteoblasts (both P<0.05). HLE at 100 microg/mL increased the osteoblastic ALP activities, and HLE at all dose enhanced the extracellular matrix mineralization (both P<0.01). Furthermore, compared with the control group, HLE at 20 microg/mL and 100 microg/mL inhibited osteoclastic TRAP activity (P<0.01), and reduced the expression of matrix metalloproteinase-9 and cathepsin K (both P<0.05). CONCLUSION: HLE may protect against bone loss, and have potentials in the treatment of osteoporosis. FAU - Xia, Tian-Shuang AU - Xia TS AD - Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, (200433), China. FAU - Lin, Liu-Yue AU - Lin LY AD - School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, (350108), China. FAU - Zhang, Qiao-Yan AU - Zhang QY AD - Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, (200433), China. FAU - Jiang, Yi-Ping AU - Jiang YP AD - Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, (200433), China. FAU - Li, Chang-Hui AU - Li CH AD - Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, (200433), China. FAU - Liu, Xiao-Yan AU - Liu XY AD - Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, (200433), China. FAU - Qin, Lu-Ping AU - Qin LP AD - School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, (310053), China. FAU - Xin, Hai-Liang AU - Xin HL AD - Department of Pharmacognosy, School of Pharmacy, Second Military Medical University, Shanghai, (200433), China. hailiangxin@163.com. LA - eng PT - Journal Article DEP - 20190327 PL - China TA - Chin J Integr Med JT - Chinese journal of integrative medicine JID - 101181180 RN - 0 (Plant Extracts) SB - IM MH - Animals MH - *Humulus MH - Mice MH - Mice, Inbred ICR MH - Osteoblasts MH - Osteoclasts MH - *Osteoporosis/drug therapy/prevention & control MH - Ovariectomy MH - Plant Extracts/pharmacology/therapeutic use MH - X-Ray Microtomography OTO - NOTNLM OT - Humulus lupulus L. OT - osteoblasts OT - osteoclasts OT - osteoporosis OT - ovariectomy-induced mice EDAT- 2019/03/29 06:00 MHDA- 2021/11/09 06:00 CRDT- 2019/03/29 06:00 PHST- 2018/08/31 00:00 [accepted] PHST- 2019/03/29 06:00 [pubmed] PHST- 2021/11/09 06:00 [medline] PHST- 2019/03/29 06:00 [entrez] AID - 10.1007/s11655-019-2700-z [pii] AID - 10.1007/s11655-019-2700-z [doi] PST - ppublish SO - Chin J Integr Med. 2021 Jan;27(1):31-38. doi: 10.1007/s11655-019-2700-z. Epub 2019 Mar 27.